Similarly, patients carrying these unfavorable genetic changes exhibited a significantly higher membrane TLR2 expression determined by MFI comparing to the CLL patients without these abnormalities (p < 0.01) (Fig. 5b; Table 2). This evidence concerns the gene TLR2 and B-cell chronic lymphocytic leukemia.